ArticleBone marrow transplantation2009
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML.
R K Malladi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it